Does the aggressive facility expansion reported this week (#msg-11705098) suggest to you that Merrimack has seen at least some of the MM-093 results in RA? A prior PR said the RA data would be available around now, and inking an expensive new lease would seem to be reckless if the clinical data on the company’s most advanced program were bad. T.i.a. Dew
Market Data 
Markets 
AI
